Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia (2019)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; LACCHINI, FERNANDA BORCHERS COELI - FCFRP
- Unidades: FMRP; EERP; FCFRP
- DOI: 10.1080/10641955.2019.1582664
- Subjects: POLIMORFISMO; PRÉ-ECLÂMPSIA
- Keywords: Preeclampsia; Oxidative stress; Plasma HO-1; Polymorphism; plasma sFLT-1
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Hypertension in Pregnancy
- ISSN: 2210-7789
- Volume/Número/Paginação/Ano: v. 38, n. 2, p. 73-77, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SANDRIM, Valéria Cristina et al. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, v. 38, n. 2, p. 73-77, 2019Tradução . . Disponível em: https://doi.org/10.1080/10641955.2019.1582664. Acesso em: 27 abr. 2024. -
APA
Sandrim, V. C., Coeli-Lacchini, F. B., Tanus-Santos, J. E., Lacchini, R., & Cavalli, R. de C. (2019). Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, 38( 2), 73-77. doi:10.1080/10641955.2019.1582664 -
NLM
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1080/10641955.2019.1582664 -
Vancouver
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1080/10641955.2019.1582664 - Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia
- ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia
- Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
Informações sobre o DOI: 10.1080/10641955.2019.1582664 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
